$XXII | 22nd Century Group Patent Portfolio Focused on $700 Billion Market
25 Apr
2016
Written by Mike Elliott

$XXII | 22nd Century Group Patent Portfolio Focused on $700 Billion Market »

In this episode we will be talking to Mr. Gregg Gellman, Director of Business Development and Regulatory Affairs for 22nd Century Group, a plant biotechnology company that is a leader in tobacco harm reduction and trades under ticker XXII.

Read more...

Login

Lost your password?